Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

132.30
Delayed Data
As of Jun 28
 +1.36 / +1.04%
Today’s Change
98.61
Today|||52-Week Range
169.89
-7.76%
Year-to-Date

Today’s Trading

Previous close130.94
Today’s open132.01
Day’s range131.07 - 132.68
Volume324,500
Average volume (3 months)614,624
Market cap$6.0B
Dividend yield--
Data as of 06/28/2017

Growth & Valuation

Earnings growth (last year)+19.89%
Earnings growth (this year)-6.27%
Earnings growth (next 5 years)-6.70%
Revenue growth (last year)+9.08%
P/E ratio9.3
Price/Sales4.20
Price/Book3.07

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...+0.50+3.00%
GRFSGrifols SA-0.04-0.19%
IONSIonis Pharmaceutical...+1.44+2.74%
PTHNPatheon NV+0.01+0.03%
Data as of 06/28/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$3.49
Annual revenue (last year)$1.6B
Annual profit (last year)$713.7M
Net profit margin44.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts